CONCERT PHARMACEUTICALS INC (CNCE) Stock Balance Sheet
NASDAQ:CNCE - Nasdaq - US2060221056 - Common Stock - Currency: USD
| MRQ (2022-9-30) | 2021 (2021-12-31) | 2020 (2020-12-31) | 2019 (2019-12-31) | 2018 (2018-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash | 10.38M | 8.79M | 7.30M | 10.30M | 8.40M | |||
| Cash Equivalents | 84.81M | 132.85M | 69.90M | 42.80M | 9.40M | |||
| Marketable Securities | 54.34M | 1.46M | 54.70M | 58.80M | 143.10M | |||
| Receivables | 1.65M | 218.00K | 3.20M | 300.00K | 16.60M | |||
| Other Current Assets | 6.01M | 7.01M | 7.60M | 4.70M | 2.70M | |||
| Total Current Assets | 157.20M | 150.33M | 142.70M | 116.90M | 180.10M | |||
| Non-Current Assets | ||||||||
| PPE Net | 12.78M | 13.83M | 15.30M | 17.00M | 8.90M | |||
| Other Non-Current Assets | 1.16M | 1.16M | 1.20M | 1.30M | 1.20M | |||
| Total Non-Current Assets | 13.94M | 14.99M | 16.60M | 20.60M | 12.40M | |||
| TOTAL ASSETS | 171.13M | 165.32M | 159.30M | 137.50M | 192.50M | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Current Portion Of LT Debt. | N/A | N/A | N/A | N/A | N/A | |||
| Accrued Expenses | 4.72M | 5.87M | 5.30M | 4.40M | 3.70M | |||
| Accounts Payable | 2.75M | 2.61M | 200.00K | 900.00K | 1.30M | |||
| Other Current Liabilities | 9.93M | 7.65M | 4.60M | 12.00M | 3.70M | |||
| Total Current Liabilities | 17.40M | 16.12M | 10.20M | 17.30M | 8.70M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Other Non-Current Liabilities | 20.46M | 36.97M | 17.90M | 18.70M | 16.10M | |||
| Total Non-Current Liabilities | 20.46M | 36.97M | 17.90M | 18.70M | 16.10M | |||
| TOTAL LIABILITIES | 37.86M | 53.09M | 28.10M | 36.00M | 24.80M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -440.05M | -349.50M | -269.40M | -194.70M | -116.50M | |||
| Additional Paid In Capital | 573.41M | 461.76M | 400.60M | 296.10M | 284.40M | |||
| Common Shares | 45.00K | 34.00K | 0.00 | 0.00 | 0.00 | |||
| Other Shareholders' Equity | -134.00K | -76.00K | -100.00K | 0.00 | N/A | |||
| Shares Outstanding | 47.93M | 34.74M | 31.90M | 23.90M | 23.40M | |||
| Tangible Book Value per Share | 2.78 | 3.23 | 4.11 | 4.25 | 7.17 | |||
| Total Shareholders' Equity | 133.27M | 112.22M | 131.20M | 101.50M | 167.70M | |||
| TOTAL LIABILITIES AND EQUITY | 171.13M | 165.32M | 159.30M | 137.50M | 192.50M | |||
| Statistics | ||||||||
| Current Ratio | 9.03 | 9.33 | 13.99 | 6.76 | 20.70 | |||
| Return On Assets (ROA) | -96.07% | -48.42% | -46.96% | -56.87% | -29.09% | |||
| Return On Equity (ROE) | -123.36% | -71.33% | -57.01% | -77.04% | -33.39% | |||
| Return On Invested Capital (ROIC) | N/A | N/A | N/A | N/A | N/A | |||
| Return On Invested Capital Ex Cash (ROICexc) | N/A | N/A | N/A | N/A | N/A | |||
| Return On Invested Capital Ex Cash + Goodwill (ROICexcg) | N/A | N/A | N/A | N/A | N/A | |||
All data in USD , ROIC based on taxRate of 0.21